Advances in biomarker discovery for peripartum cardiomyopathy: current status and future directions
Multi-marker strategies are essential to address PPCM heterogeneity and improve diagnostic accuracy. Future research should validate these biomarkers, refine diagnostic tools, and explore therapeutic applications to transform PPCM management and outcomes.
Authors
- Tawanda Zininga (ORCID: https://orcid.org/0000-0001-8689-0152)
- Alison Barnet
- Sadahiro Sai (ORCID: https://orcid.org/0000-0002-2573-2676)
- Graham Chakafana (ORCID: https://orcid.org/0009-0000-1316-116X)
- Vitaris Kodogo (ORCID: https://orcid.org/0000-0001-9167-9925)
- Erin Pretorius (ORCID: https://orcid.org/0000-0002-2727-7371)
- Karen Sliwa
Institutions
- Hampton University (US)
- University of Zimbabwe (ZW)
- University of Cape Town (ZA)
- Stellenbosch University (ZA)
Publication Details
- Journal
- Expert Review of Cardiovascular Therapy
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1080/14779072.2025.2591796
- Primary Topic
- Cardiovascular Issues in Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00